Author:
Bouquet Emilie,Eiden Céline,Fauconneau Bernard,Pion Charlotte,Louise Carton,Cécile Chevalier,Amélie Daveluy,Christine Fournier-Choma,Julie Heredia,Marion Istvan,Emilie Jouanjus,Hélène Peyrière,Liselotte Pochard,Bruno Revol,Véronique Savignat,Juliana Tournebize,Pain Stéphanie,Pérault-Pochat Marie-Christine,
Abstract
AbstractCannabis is the main illicit psychoactive substance used by pregnant women in France. The aim of the present national survey was to describe adverse events (AEs) of recreational cannabis use during pregnancy reported to the French Addictovigilance Network (FAN). Spontaneous reports (SRs) of AEs related to recreational cannabis use during pregnancy were collected by the FAN between 01/01/2011 and 31/01/2021 (excluding cannabidiol and synthetic cannabinoids). Over the study period, 160 SRs involved cannabis use alone or in association with tobacco (59% of all SRs) which increased. Among the 175 maternal AEs, the most commons were psychiatric AEs experienced by 96 (64.9%) women, in particular cannabis use disorders (n = 89, 60.1%), dependence (n = 54, 36.5%) and abuse (n = 21, 14.2%). Among the 57 fetal AEs, the most common were heart rhythm disorders that affected 25 (16.9%) fetuses and intrauterine growth restriction (IUGR) (n = 20, 13.5%). Among the 140 neonatal AEs, the most common were IUGR experienced by 39 (26.3%) newborns and prematurity (n = 32, 21.6%). Twelve cases of congenital malformations were observed and 4 intrauterine/neonatal deaths. Furthermore, some of these AEs (n = 13) were unexpected. Cannabis use during pregnancy has problematic consequences for both mothers and infants who need close monitoring.
Publisher
Springer Science and Business Media LLC
Reference38 articles.
1. Observatoire Français des Drogues et Toxicomanies. Santé Publique France. Les niveaux d’usages des drogues illicites en France en 2017, Tendances 128, Novembre 2018. https://www.ofdt.fr/publications/collections/periodiques/lettre-tendances/les-niveaux-dusages-des-drogues-illicites-en-france-en-2017-tendances-128-novembre-2018/. Accessed 3 December 2021. (2018).
2. Blackard, C. & Tennes, K. Human placental transfer of cannabinoids. N. Engl. J. Med. 311, 797. https://doi.org/10.1056/NEJM198409203111213 (1984).
3. Boskovic, R., Klein, J., Woodland, C., Karaskov, T. & Koren, G. The role of the placenta in variability of fetal exposure to cocaine and cannabinoids: A twin study. Can. J. Physiol. Pharmacol. 79, 942–945 (2001).
4. Institut National de la Santé et de la Recherche Médicale – Direction de la Recherche, des Etudes, de l’Evaluation et des Statistiques. Enquête Nationale Périnatale. Rapport 2016. Les naissances et les Etablissements. Situation et Evolution Depuis 2010. http://www.xn--epop-inserm-ebb.fr/wp-content/uploads/2017/10/ENP2016_synthese_rapport.pdf. Accessed 5 November 2021. (2017).
5. Blayac, L., Micallef, J. & Lapeyre-Mestre, M. Evolution des comportements de consommation de produits psychoactifs illicites ou détournés de leur usage médicamenteux chez les femmes enceintes en France: Analyse des données OPPIDUM de 2005 à 2018. Therapies 76, 169 (2021).
Cited by
2 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献